Lara Klett

Lara Klett

Deutsches Krebsforschungszentrum - Heidelberg / Germany
Others
AD Scientific Index ID: 4564764
German Cancer Research Centre
person_outline Lara Klett's MOST POPULAR ARTICLES
1-) Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivoA Chaturvedi, L Herbst, S Pusch, L Klett, R Goparaju, D Stichel, ...Leukemia 31 (10), 2020, 20171182017
2-) Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networksJP Mallm, M Iskar, N Ishaque, LC Klett, SJ Kugler, JM Muino, VB Teif, ...Molecular Systems Biology 15 (5), e8339, 2019362019
3-) Genome-scale reconstruction of the Streptococcus pyogenes M49 metabolic network reveals growth requirements and indicates potential drug targetsJ Levering, T Fiedler, A Sieg, KWA van Grinsven, S Hering, N Veith, ...Journal of biotechnology 232, 25-37, 2016262016
4-) Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLLJA Wierzbinska, R Toth, N Ishaque, K Rippe, JP Mallm, LC Klett, ...Genome medicine 12 (1), 1-19, 2020172020
5-) Pan-Mutant-IDH1 Inhibitor Bay-1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia In VivoM Heuser, L Herbst, S Pusch, L Klett, R Goparaju, D Stichel, S Kaulfuss, ...Blood, The Journal of the American Society of Hematology 128 (22), 745-745, 201692016